343 related articles for article (PubMed ID: 17675496)
1. Fimbrial proteins of porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and complement receptor 3 to persist in macrophages.
Wang M; Shakhatreh MA; James D; Liang S; Nishiyama S; Yoshimura F; Demuth DR; Hajishengallis G
J Immunol; 2007 Aug; 179(4):2349-58. PubMed ID: 17675496
[TBL] [Abstract][Full Text] [Related]
2. Complement receptor 3 blockade promotes IL-12-mediated clearance of Porphyromonas gingivalis and negates its virulence in vivo.
Hajishengallis G; Shakhatreh MA; Wang M; Liang S
J Immunol; 2007 Aug; 179(4):2359-67. PubMed ID: 17675497
[TBL] [Abstract][Full Text] [Related]
3. Subversion of innate immunity by periodontopathic bacteria via exploitation of complement receptor-3.
Hajishengallis G; Wang M; Liang S; Shakhatreh MA; James D; Nishiyama S; Yoshimura F; Demuth DR
Adv Exp Med Biol; 2008; 632():203-19. PubMed ID: 19025124
[TBL] [Abstract][Full Text] [Related]
4. Importance of TLR2 in early innate immune response to acute pulmonary infection with Porphyromonas gingivalis in mice.
Hajishengallis G; Wang M; Bagby GJ; Nelson S
J Immunol; 2008 Sep; 181(6):4141-9. PubMed ID: 18768871
[TBL] [Abstract][Full Text] [Related]
5. Mechanism and implications of CXCR4-mediated integrin activation by Porphyromonas gingivalis.
Hajishengallis G; McIntosh ML; Nishiyama SI; Yoshimura F
Mol Oral Microbiol; 2013 Aug; 28(4):239-49. PubMed ID: 23331495
[TBL] [Abstract][Full Text] [Related]
6. Macrophage-specific TLR2 signaling mediates pathogen-induced TNF-dependent inflammatory oral bone loss.
Papadopoulos G; Weinberg EO; Massari P; Gibson FC; Wetzler LM; Morgan EF; Genco CA
J Immunol; 2013 Feb; 190(3):1148-57. PubMed ID: 23264656
[TBL] [Abstract][Full Text] [Related]
7. The Distinct Immune-Stimulatory Capacities of Porphyromonas gingivalis Strains 381 and ATCC 33277 Are Determined by the
Coats SR; Kantrong N; To TT; Jain S; Genco CA; McLean JS; Darveau RP
Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31570556
[TBL] [Abstract][Full Text] [Related]
8. Increases in IL-33 production by fimbriae and lipopeptide from Porphyromonas gingivalis in mouse bone marrow-derived dendritic cells via Toll-like receptor 2.
Tada H; Suzuki R; Nemoto E; Shimauchi H; Matsushita K; Takada H
Biomed Res; 2017; 38(3):189-195. PubMed ID: 28637954
[TBL] [Abstract][Full Text] [Related]
9. Porphyromonas gingivalis 67-kDa fimbriae induced cytokine production and osteoclast differentiation utilizing TLR2.
Hiramine H; Watanabe K; Hamada N; Umemoto T
FEMS Microbiol Lett; 2003 Dec; 229(1):49-55. PubMed ID: 14659542
[TBL] [Abstract][Full Text] [Related]
10. Host adhesive activities and virulence of novel fimbrial proteins of Porphyromonas gingivalis.
Pierce DL; Nishiyama S; Liang S; Wang M; Triantafilou M; Triantafilou K; Yoshimura F; Demuth DR; Hajishengallis G
Infect Immun; 2009 Aug; 77(8):3294-301. PubMed ID: 19506009
[TBL] [Abstract][Full Text] [Related]
11. Identification of signaling pathways in macrophage exposed to Porphyromonas gingivalis or to its purified cell wall components.
Zhou Q; Amar S
J Immunol; 2007 Dec; 179(11):7777-90. PubMed ID: 18025224
[TBL] [Abstract][Full Text] [Related]
12. Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function.
Hajishengallis G; Wang M; Liang S; Triantafilou M; Triantafilou K
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13532-7. PubMed ID: 18765807
[TBL] [Abstract][Full Text] [Related]
13. Differential virulence and innate immune interactions of Type I and II fimbrial genotypes of Porphyromonas gingivalis.
Wang M; Liang S; Hosur KB; Domon H; Yoshimura F; Amano A; Hajishengallis G
Oral Microbiol Immunol; 2009 Dec; 24(6):478-84. PubMed ID: 19832800
[TBL] [Abstract][Full Text] [Related]
14. Peptide mapping of bacterial fimbrial epitopes interacting with pattern recognition receptors.
Hajishengallis G; Ratti P; Harokopakis E
J Biol Chem; 2005 Nov; 280(47):38902-13. PubMed ID: 16129673
[TBL] [Abstract][Full Text] [Related]
15. TLR2 promoter hypermethylation creates innate immune dysbiosis.
Benakanakere M; Abdolhosseini M; Hosur K; Finoti LS; Kinane DF
J Dent Res; 2015 Jan; 94(1):183-91. PubMed ID: 25389002
[TBL] [Abstract][Full Text] [Related]
16. Differential capacity for complement receptor-mediated immune evasion by Porphyromonas gingivalis depending on the type of innate leukocyte.
Hajishengallis G; Krauss JL; Jotwani R; Lambris JD
Mol Oral Microbiol; 2017 Apr; 32(2):154-165. PubMed ID: 27081768
[TBL] [Abstract][Full Text] [Related]
17. Porphyromonas gingivalis fimbriae dampen P2X7-dependent interleukin-1β secretion.
Morandini AC; Ramos-Junior ES; Potempa J; Nguyen KA; Oliveira AC; Bellio M; Ojcius DM; Scharfstein J; Coutinho-Silva R
J Innate Immun; 2014; 6(6):831-45. PubMed ID: 24925032
[TBL] [Abstract][Full Text] [Related]
18. Cutting Edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption.
Burns E; Bachrach G; Shapira L; Nussbaum G
J Immunol; 2006 Dec; 177(12):8296-300. PubMed ID: 17142724
[TBL] [Abstract][Full Text] [Related]
19. Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein.
Zhou Q; Desta T; Fenton M; Graves DT; Amar S
Infect Immun; 2005 Feb; 73(2):935-43. PubMed ID: 15664935
[TBL] [Abstract][Full Text] [Related]
20.
Makkawi H; Hoch S; Burns E; Hosur K; Hajishengallis G; Kirschning CJ; Nussbaum G
Front Cell Infect Microbiol; 2017; 7():359. PubMed ID: 28848717
[No Abstract] [Full Text] [Related]
[Next] [New Search]
